Kenji Momota

Biologically Active Oligodeoxyribonucleotides. 5. 5‘-End-Substituted d(TGGGAG) Possesses Anti-Human Immunodeficiency Virus Type 1 Activity by Forming a G-Quadruplex Structure

Hitoshi Hotoda, Makoto Koizumi, Rika Koga et al. · Journal of Medicinal Chemistry · 1998 · 91 citations

Life Sciences, Biochemistry, Pharmacology +17

Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: A new class of anti-HIV agents

Masahiko Hagihara, Hiroto Kashiwase, Tetsushi Katsube et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 47 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Genetic Analysis of HIV-1 during Rapid Progression to AIDS in an Apparently Healthy Man

Shinichi Oka, Tatsuo Shioda, Y Takebe et al. · AIDS Research and Human Retroviruses · 1994 · 45 citations

Life Sciences, Genetics, Infectious Diseases +15

Biologically active oligodeoxyribonucleotides—IX.1 Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3′- and 5′-end-modification

Makoto Koizumi, Rika Koga, Hitoshi Hotoda et al. · Bioorganic & Medicinal Chemistry · 1997 · 41 citations

Life Sciences, Biochemistry, Molecular Biology +15

Biologically Active Oligodeoxyribonucleotides - II¹: Structure Activity Relationships of Anti-HIV-1 Pentadecadeoxyribonucleotides Bearing 5′-End-Modifications

Hitoshi Hotoda, Kenji Momota, Hidehiko Furukawa et al. · Nucleosides and Nucleotides · 1994 · 27 citations

Pharmacy, Medicinal Chemistry, Molecular Biology +16